Digital

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline
AIAI Proteins

Astellas Pharma Partners With AI Proteins in Computational Drug Discovery Deal Worth Over USD 400 Million – Access to Miniprotein Design Platform to Strengthen Early-Stage Pipeline

Astellas Pharma Inc. (TYO: 4503) announced a collaboration with AI Proteins, a Boston‑based computational drug discovery company, in a deal with a total potential value exceeding USD 400 million. Under…

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Insilico Medicine and MobiDrop Sign Strategic Partnership to Advance AI‑Ready Single‑Cell Data for Drug Discovery

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI‑Driven Patient Care in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
CancerE-commerce

Hywin Holdings to Acquire Life Infinity for Health Management Expansion

AIBrainCo

Pica Partners with BrainCo to Launch ADHD Product in China

E-commerceOnline hospitals

Sanofi’s Hornstein Sees China’s Online Hospitals Boosting Digital Health Strategy

ApolloBioBiotech

ApolloBio Corp. Initiates Pre-Clinical Study for ABC-5100 Nanobody Against COVID-19

Show More